Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-associated Malignancies
Clinical trial NCT03988582 · WITHDRAWN
Trial details
- NCT number
- NCT03988582
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-11
- Primary completion
- 2020-06-08
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.